Interestingly, regarding the single expression of TIGIT and CD39, we observed no significant differences in the frequency of TIGIT+ and CD39+ NK cells when we compared the PB from AML patients with that of HDs, whereas the expression of LAG-3 was only increased in the PB of AML patients. The gene discussed is LAG3; the disease is acute myeloid leukemia.